Anomalous behaviour of the STAT3 binding site in the human c-myc P2 promoter

Biochemical and Biophysical Research Communications

Volumn 364, Issue 3, 2007, Pages 627-632

  Vougier, Stéphanie ^a   Cheung, Shing Hu ^a   Li, Li ^a   Hodgson, Glenn ^a   Shaw, Peter E ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Acute phase response; Cell cycle; Pre initiation complex; Transcription

Indexed keywords

CYTOKINE; MYC PROTEIN; PROTEIN C FOS; PROTEIN P2; STAT1 PROTEIN; STAT3 PROTEIN;

ACUTE PHASE RESPONSE; ANIMAL CELL; ARTICLE; BINDING SITE; CARCINOGENICITY; CELL LINE; CELL PROLIFERATION; CELL RENEWAL; CELL SPECIFICITY; CELL TYPE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE RESPONSIVE ELEMENT; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; INFLAMMATION; LIVER; NONHUMAN; PLEIOTROPY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN FUNCTION;

BINDING SITES; CELL LINE; DNA-BINDING PROTEINS; HEPATOCYTES; HUMANS; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; STAT3 TRANSCRIPTION FACTOR; TRANSCRIPTION FACTORS;

VERTEBRATA;

EID: 35649026743     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.10.044     Document Type: Article

References (26)

1. Bowman T., Garcia R., Turkson J., and Jove R. STATs in oncogenesis. Oncogene 19 (2000) 2474-2488
2. Turkson J., Bowman T., Garcia R., Caldenhoven E., De Groot R.P., and Jove R. Stat3 activation by Src induces specific gene regulation and is required for cell transformation. Mol. Cell. Biol. 18 (1998) 2545-2552
3. Bromberg J.F., Wrzeszczynska M.H., Devgan G., Zhao Y., Pestell R.G., Albanese C., and Darnell J.E.J. Stat3 as an oncogene. Cell 98 (1999) 295-303
4. Alvarez J.V., and Frank D.A. Genome-wide analysis of STAT target genes: elucidating the mechanism of STAT-mediated oncogenesis. Cancer Biol. Ther. 3 (2004) 1045-1050
5. Dauer D.J., Ferraro B., Song L., Yu B., Mora L., Buettner R., Enkemann S., Jove R., and Haura E.B. Stat3 regulates genes common to both wound healing and cancer. Oncogene 24 (2005) 3397-3408
6. Wegenka U.M., Lutticken C., Buschmann J., Yuan J., Lottspeich F., Muller-Esterl W., Schindler C., Roeb E., Heinrich P.C., and Horn F. The interleukin-6-activated acute-phase response factor is antigenically and functionally related to members of the signal transducer and activator of transcription (STAT) family. Mol. Cell. Biol. 14 (1994) 3186-3196
7. Raz R., Durbin J.E., and Levy D.E. Acute phase response factor and additional members of the interferon-stimulated gene factor 3 family integrate diverse signals from cytokines, interferons, and growth factors. J. Biol. Chem. 269 (1994) 24391-24395
8. Alonzi T., Maritano D., Gorgoni B., Rizzuto G., Libert C., and Poli V. Essential role of STAT3 in the control of the acute-phase response as revealed by inducible gene inactivation in the liver. Mol. Cell. Biol. 21 (2001) 1621-1632
9. Takeda K., Clausen B.E., Kaisho T., Tsujimura T., Terada N., Forster I., and Akira S. Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. Immunity 10 (1999) 39-49
10. Riley J.K., Takeda K., Akira S., and Schreiber R.D. Interleukin-10 receptor signaling through the JAK-STAT pathway. Requirement for two distinct receptor-derived signals for anti-inflammatory action. J. Biol. Chem. 274 (1999) 16513-16521
11. Heinrich P.C., Behrmann I., Haan S., Hermanns H.M., Muller-Newen G., and Schaper F. Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem. J. 374 (2003) 1-20
12. Kiuchi N., Nakajima K., Ichiba M., Fukada T., Narimatsu M., Mizuno K., Hibi M., and Hirano T. STAT3 is required for the gp130-mediated full activation of the c-myc gene. J. Exp. Med. 189 (1999) 63-73
13. Dignam J.D., Lebovitz R.M., and Roeder R.G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11 (1983) 1475-1489
14. Li L., and Shaw P.E. Autocrine-mediated activation of STAT3 correlates with cell proliferation in breast carcinoma lines. J. Biol. Chem. 277 (2002) 17397-17405
15. Boussif O., Lezoualc'h F., Zanta M.A., Mergny M.D., Scherman D., Demeneix B., and Behr J.P. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc. Natl. Acad. Sci. USA 92 (1995) 7297-7301
16. Ranish J.A., Yudkovsky N., and Hahn S. Intermediaries in formation and activity of the RNA polymerase II preinitiation complex: holoenzyme recruitment and a postrecruitment role for the TATA box and TFIIB. Genes Dev. 13 (1999) 49-63
17. Drewett V., Molina H., Millar A., Muller S., von Hesler F., and Shaw P.E. DNA-bound transcription factor complexes analysed by mass-spectrometry: binding of novel proteins to the human c-fos SRE and related sequences. Nucleic Acids Res. 29 (2001) 479-487
18. Wagner B.J., Hayes T.E., Hoban C.J., and Cochran B.H. The SIF binding element confers sis/PDGF inducibility onto the c-fos promoter. EMBO J. 9 (1990) 4477-4484
19. Barre B., Avril S., and Coqueret O. Opposite regulation of myc and p21waf1 transcription by STAT3 proteins. J. Biol. Chem. 278 (2003) 2990-2996
20. Li L., and Shaw P.E. Elevated activity of STAT3C due to higher DNA binding affinity of phosphotyrosine dimer rather than covalent dimer formation. J. Biol. Chem. 281 (2006) 33172-33181
21. Shang Y., Hu X., DiRenzo J., Lazar M.A., and Brown M. Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell. 103 (2000) 843-852
22. Drewett V., Devitt A., Saxton J., Portman N., Greaney P., Cheong N., Alnemri T.F., Alnemri E., and Shaw P.E. Serum response factor (SRF) cleavage by caspases 3 and 7 linked to apoptosis in human BJAB cells. J. Biol. Chem. 276 (2001) 33444-33451
23. Vigneron A., Cherier J., Barre B., Gamelin E., and Coqueret O. The cell cycle inhibitor p21waf1 binds to the myc and cdc25A promoters upon DNA damage and induces transcriptional repression. J. Biol. Chem. 281 (2006) 34742-34750
24. Ehret G.B., Reichenbach P., Schindler U., Horvath C.M., Fritz S., Nabholz M., and Bucher P. DNA binding specificity of different STAT proteins. Comparison of in vitro specificity with natural target sites. J. Biol. Chem. 276 (2001) 6675-6688
25. 2-terminal domains stabilizes binding of two dimers to tandem DNA sites. EMBO J. 15 (1996) 5616-5626
26. Gao B. Cytokines, STATs and liver disease. Cell. Mol. Immunol. 2 (2005) 92-100